QUICKI Calculator
Free QUICKI Calculator with medically-sourced formulas. Enter your measurements for personalized, accurate health insights.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
QUICKI Calculator
Calculator
Adjust values & calculateEnter your values below. Every result is computed in your browser — no data is sent to any server.
Formula: QUICKI = 1 / (log10(Fasting Insulin) + log10(Fasting Glucose))
Worked example — QUICKI = 0.3805 (Borderline Normal) | HOMA-IR = 1.05 | Good sensitivity
Formula
QUICKI = 1 / (log10(Fasting Insulin) + log10(Fasting Glucose))
Where Fasting Insulin is in microU/mL and Fasting Glucose is in mg/dL. Higher QUICKI values indicate better insulin sensitivity. Normal is above 0.382, borderline is 0.339-0.382, and below 0.339 indicates insulin resistance. Below 0.30 signifies significant resistance.
Worked Examples
Example 1: Normal Insulin Sensitivity
Problem:Calculate QUICKI for a patient with fasting glucose of 85 mg/dL and fasting insulin of 5 microU/mL.
Solution:QUICKI = 1 / (log10(5) + log10(85)) QUICKI = 1 / (0.6990 + 1.9294) QUICKI = 1 / 2.6284 QUICKI = 0.3805 HOMA-IR = (4.72 x 5) / 22.5 = 1.05 This indicates borderline-normal insulin sensitivity
Result:QUICKI = 0.3805 (Borderline Normal) | HOMA-IR = 1.05 | Good sensitivity
Example 2: Insulin Resistance Detection
Problem:Calculate QUICKI for a patient with fasting glucose of 120 mg/dL and fasting insulin of 25 microU/mL.
Solution:QUICKI = 1 / (log10(25) + log10(120)) QUICKI = 1 / (1.3979 + 2.0792) QUICKI = 1 / 3.4771 QUICKI = 0.2876 HOMA-IR = (6.66 x 25) / 22.5 = 7.40 Significant insulin resistance detected
Result:QUICKI = 0.2876 (Low) | HOMA-IR = 7.40 | Significant insulin resistance
Frequently Asked Questions
What is the QUICKI index and how does it measure insulin sensitivity?
QUICKI stands for Quantitative Insulin Sensitivity Check Index. It is a mathematical formula that estimates insulin sensitivity using fasting glucose and fasting insulin levels from a single blood draw. Developed by Katz et al. in 2000, QUICKI uses a logarithmic transformation to linearize the relationship between insulin and glucose, providing a more normally distributed measure compared to HOMA-IR. The formula is QUICKI = 1 / (log10 fasting insulin + log10 fasting glucose). Higher QUICKI values indicate better insulin sensitivity, with normal values typically above 0.382. QUICKI has been validated against the gold standard euglycemic-hyperinsulinemic clamp and shows correlation coefficients of 0.78-0.89, making it one of the most accurate surrogate measures available.
How is QUICKI calculated and what do the numbers mean?
QUICKI is calculated as the inverse of the sum of the base-10 logarithms of fasting insulin (in microU/mL) and fasting glucose (in mg/dL). The logarithmic transformation is key because the relationship between insulin and glucose is nonlinear, and log transformation produces a more linear and normally distributed output. Normal QUICKI values range from 0.382 to 0.450, with higher values indicating greater insulin sensitivity. Values between 0.339 and 0.382 suggest borderline insulin sensitivity. Values below 0.339 indicate insulin resistance, and values below 0.30 suggest significant insulin resistance associated with metabolic syndrome. Unlike HOMA-IR where higher values indicate worse outcomes, higher QUICKI values indicate better insulin sensitivity.
How does QUICKI compare to HOMA-IR for measuring insulin resistance?
QUICKI and HOMA-IR are mathematically related but use different transformations. HOMA-IR multiplies glucose by insulin and divides by a constant, while QUICKI uses logarithmic transformation. Several comparative studies have shown that QUICKI correlates more closely with clamp-derived insulin sensitivity than HOMA-IR, particularly in obese individuals and those with significantly impaired insulin sensitivity. The logarithmic transformation in QUICKI better captures the nonlinear relationship between insulin and glucose at extreme values. However, both measures use the same input data (fasting glucose and insulin), so they are highly correlated with each other. Many researchers report both values for completeness. QUICKI is particularly favored in research settings due to its better statistical properties and normal distribution.
What factors can affect QUICKI results and how can accuracy be improved?
Several factors affect QUICKI accuracy. The most important is proper fasting: patients must fast for 8-12 hours, and samples should be drawn in the morning between 7-10 AM to minimize circadian variation. Stress, poor sleep, and acute illness can elevate cortisol and catecholamines, affecting both glucose and insulin levels. Certain medications including steroids, beta-blockers, thiazide diuretics, and atypical antipsychotics can alter insulin sensitivity and should be noted when interpreting results. Hemolysis of the blood sample can falsely lower insulin measurements. For maximum reliability, consider averaging results from two or three separate fasting blood draws taken on different days. The coefficient of variation for QUICKI is approximately 10-15%, meaning small changes between measurements may not be clinically significant.
Can QUICKI be used to monitor treatment response over time?
QUICKI is an excellent tool for monitoring treatment response because it is sensitive to changes in insulin sensitivity induced by interventions. Weight loss studies have shown that QUICKI values increase by 0.02-0.05 points with 5-10% body weight reduction, reflecting improved insulin sensitivity. Exercise interventions typically improve QUICKI by 0.01-0.03 points within 8-12 weeks. Metformin treatment can increase QUICKI by 0.02-0.04 points, while thiazolidinediones may improve it by 0.03-0.06 points. When monitoring treatment response, consistent testing conditions are critical for comparing values over time. A clinically meaningful change in QUICKI is generally considered to be at least 0.02 points, given the inherent biological variability.
What is the revised QUICKI and how does it differ from standard QUICKI?
The revised QUICKI (rQUICKI) adds a third variable, fasting free fatty acids (FFA), to the standard formula: rQUICKI = 1 / (log10 insulin + log10 glucose + log10 FFA). The inclusion of free fatty acids improves the accuracy of insulin sensitivity estimation because FFAs play a critical role in insulin resistance through lipotoxicity and impaired insulin signaling pathways. Studies have shown that rQUICKI correlates even more strongly with clamp-derived insulin sensitivity than standard QUICKI, particularly in obese individuals and those with non-alcoholic fatty liver disease. However, rQUICKI requires an additional lab measurement that is not routinely available, limiting its practical application in clinical settings compared to the standard QUICKI formula.
Who should get tested with QUICKI and how often should testing occur?
QUICKI testing is recommended for individuals at risk for insulin resistance and type 2 diabetes. This includes people with a body mass index above 25, family history of type 2 diabetes, history of gestational diabetes, polycystic ovary syndrome (PCOS), sedentary lifestyle, and ethnic groups with higher diabetes prevalence. For those with identified risk factors, annual testing is generally recommended to track insulin sensitivity trends over time. Patients diagnosed with prediabetes or metabolic syndrome benefit from testing every 6 months to monitor the effectiveness of lifestyle interventions. The test requires only a standard fasting blood panel that includes insulin, making it cost-effective and easily integrated into routine health screenings.
How does QUICKI relate to metabolic syndrome and cardiovascular risk?
Low QUICKI values are strongly associated with metabolic syndrome components and elevated cardiovascular risk. Research published in the Journal of Clinical Endocrinology and Metabolism has demonstrated that individuals with QUICKI values below 0.339 have significantly higher rates of abdominal obesity, dyslipidemia, hypertension, and impaired fasting glucose. Insulin resistance, as measured by QUICKI, is considered the central pathophysiological driver of metabolic syndrome. Furthermore, low QUICKI values independently predict cardiovascular events, atherosclerosis progression, and endothelial dysfunction. Studies have shown that for each 0.01 decrease in QUICKI below 0.35, cardiovascular event risk increases by approximately 5-8%. Improving QUICKI through lifestyle modification simultaneously reduces multiple cardiovascular risk markers.
What are the limitations and potential pitfalls of using QUICKI?
While QUICKI is one of the best surrogate measures of insulin sensitivity, it has notable limitations. Like all fasting-based indices, it only captures basal insulin sensitivity and does not reflect dynamic insulin response to glucose stimulation. It is unreliable in patients taking exogenous insulin, as the measured insulin level does not reflect endogenous production. In patients with very low or very high insulin levels, the logarithmic transformation may amplify measurement errors. QUICKI assumes a steady-state metabolic condition and is less valid during acute illness, rapid weight changes, or medication adjustments. The formula does not account for hepatic versus peripheral insulin resistance, which have different clinical implications. Finally, reference ranges may vary by laboratory assay, population, age, and ethnicity.
How can QUICKI values be improved through lifestyle modifications?
Multiple evidence-based lifestyle strategies can improve QUICKI values and insulin sensitivity. Aerobic exercise of 150-300 minutes per week at moderate intensity consistently improves QUICKI by enhancing GLUT4 transporter expression and mitochondrial function in skeletal muscle. Resistance training 2-3 times weekly provides additional benefit by increasing lean muscle mass, which is the primary site of insulin-stimulated glucose uptake. Dietary modifications including increased fiber intake to 30-40g daily, Mediterranean diet adherence, and reducing refined carbohydrate and processed food consumption have all shown measurable QUICKI improvements. Weight loss remains the most impactful intervention, with each kilogram of fat loss associated with approximately 0.003-0.005 QUICKI improvement. Adequate sleep of 7-9 hours nightly and stress management through mindfulness or meditation also support insulin sensitivity improvements.
References
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮Addiction Calculator
Calculate addiction with inputs, formulas, and instant results.
🧮Alcohol Unit Calculator
Calculate alcohol unit with inputs, formulas, and instant results.
🧮AUDIT-C Calculator
Calculate audit ccalculator with inputs, formulas, and instant results.
🧮AUDIT Full Questionnaire Calculator
Calculate auditfull questionnaire with inputs, formulas, and instant results.
🧮AUDIT Score Calculator
Calculate audit score with inputs, formulas, and instant results.
🧮CAGE Questionnaire Calculator
Calculate cagequestionnaire with inputs, formulas, and instant results.
🧮Cigarette Calculator
Calculate cigarette with inputs, formulas, and instant results.
🧮DAST-10 Drug Abuse Screening Calculator
Calculate dast10drug abuse with inputs, formulas, and instant results.